Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK31679 in NASH
NCT06168383Phase 2Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK31679 in Nonalcoholic steatohepatitis (NASH), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Jan 2024; status: completed.
02
Drugs
HSK31679
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT06168383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06168383.